Actions of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells

British Journal of Pharmacology

Volumn 125, Issue 3, 1998, Pages 429-436

  Arakawa, Kenji ^a   Ishihara, Tomomi ^a   Aoto, Masamichi ^a   Inamasu, Masanori ^a   Saito, Akira ^a   Ikezawa, Katsuo ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Antidiabetic agents; Insulin sensitivity; L6 cell line; Magnesium; Skeletal muscle; T 174; Thiazolidinedione

Indexed keywords

5 [2 (2 NAPHTHYLMETHYL) 5 BENZOXAZOLYLMETHYL] 2,4 THIAZOLIDINEDIONE; ANTIDIABETIC AGENT; GLUCOSE; INSULIN; INSULIN RECEPTOR; LIPID; PIOGLITAZONE; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPOMAGNESEMIA; INSULIN RESISTANCE; MALE; MOUSE; MUSCLE FIBER CULTURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; DEOXY SUGARS; DIABETES MELLITUS, TYPE 2; HYPOGLYCEMIC AGENTS; MALE; MICE; MUSCLE, SKELETAL; RATS; RATS, ZUCKER; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0031712627     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702066     Document Type: Article

References (35)

1. ARAKAWA, K., INAMASU, M., MATSUMOTO, M., OKUMURA, K., YASUDA, K., AKATSUKA, H., KAWANAMI, S., WATANABE, A., HOMMA, K., SAIGA, Y., OZEKI, M. & IIJIMA, I. (1997). Novel benzoxazole 2,4-thiazolidinediones as potent hypoglycemic agents. Synthesis and structure-activity relationships. Chem. Pharm. Bull., 45, 1984-1993.
2. BALON, T.W., JASMAN, A., SCOTT, S., MEEHAN, W.P., RUDE, R.K. & NADLER, J.L. (1994). Dietary magnesium prevents fructose-induced insulin insensitivity in rats. Hypertension, 23, 1036-1039.
3. BALON, T.W., GU, J.-L., TOKUYAMA, Y., JASMAN, A.P. & NADLER, J.L. (1995). Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am. J. Physiol., 269, E745-E752.
4. BARON, A.D., BRECHTEL, G., WALLACE, P. & EDELMAN, S.V. (1988). Rates and tissue sites of non-insulin-and insulin-mediated glucose uptake in humans. Am. J. Physiol., 255, E769-E774.
5. BARON, A.D., LAAKSO, M., BRECHTEL, G. & EDELMAN, S. V. (1991). Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy. J. Clin. Invest., 87, 1186-1194.
6. BUCHANAN, T.A., MEEHAN, W.P., JENG, Y.Y., YANG, D., CHAN, T.M., NADLER, J.L., SCOTT, S., RUDE, R.K. & HSUEH, W.A. (1995). Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J. Clin. Invest., 96, 354-360.
7. BURANT, C.F., SREENAN, S., HIRANO, K., TAL, T.-A.C., LOHMILLER, J., LUKENS, J., DAVIDSON, N.O., ROSS, S. & GRAVES, R.A. (1997). Troglitazone action is independent of adipose tissue. J. Clin. Invest., 100, 2900-2908.
8. CIARALDI, T.P., HUBER-KNUDSEN, K., HICKMAN, M. & OLEFSKY, J.M. (1995). Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents. Metabolism, 44, 976-981.
9. DE MEYTS, P. & ROTH, J. (1975). Cooperativity in ligand binding: a new graphic analysis. Biochem. Biophys. Res. Commun., 66, 1118-1126.
10. DEFRONZO, R.A., BONADONNA, R.C. & KERRANNINI, E. (1992). Pathogenesis of NIDDM. A balanced overview. Diabetes Care, 15, 318-368.
11. EL-KEBBI, I.M., ROSER, S. & POLLET, R.J. (1994). Regulation of glucose transport by pioglitazone in cultured muscle cells. Metabolism, 43, 953-958.
12. 2 is a ligand for the adipocyte determination factor PPARγ. Cell. 83, 803-812.
13. FUJIWARA, T., YOSHIOKA, S., YOSHIOKA, T., USHIYAMA, I. & HORIKOSHI, H. (1988). Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes, 37, 1549-1558.
14. FÜRNSINN, C., NESCHEN, S., NOE, C., BISSCHOP, M., RODEN, M., VOGL, C., SCHNEIDER, B. & WAEDHÄUSL, W. (1997). Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro. Br. J. Pharmacol., 122, 1367-1374.
15. GARVEY, W.T. (1992). Glucose transport and NIDDM. Diabetes Care, 15, 396-417.
16. GLIEMANN, J., ØSTERLIND, K., VINTEN, J. & GAMMEETOFT, S. (1972). A procedure for measurement of distribution spaces in isolated fat cells. Biochim. Biophys. Acta., 286, 1-9.
17. HAYAKAWA, T., SHIRAKI, T., MORIMOTO, T., SHII, K. & IKEDA, H. (1996). Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats. Biochem. Biophys. Res. Commun., 223, 439-444.
18. HAYES, N., BISWAS, C., STROUT, U.V. & BERGER, J. (1993). Activation by protein synthesis inhibitors of glucose transport into L6 muscle cells. Biochem. Biophys. Res. Commun., 190, 881-887.
19. IKEDA, H., TAKETOMI, S., SUGIYAMA, Y., SHIMURA, Y., SOHDA, T., MEGURO, K. & FUJITA, T. (1990). Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneim. Forsch., 40, 156-162.
20. KAHN, C.R. (1978). Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism, 27, 1893-1902.
21. KORANYI, L., JAMES, D.E., KRAEGEN, E.W. & PERMUTT, M.A. (1992). Feedback inhibition of insulin gene expression by insulin. J. Clin. Invest., 89, 432-436.
22. KRAEGEN, R.W., JAMES, D.E., BENNETT, S.P. & CHISHOLM, D.J. (1983). In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am. J. Physiol., 245, E1-E7.
23. LEHMANN, J.M., MOORE, L.B., SMITH-OLIVER, I.A., WILKISON, W.O., WILLSON, T.M. & KLIEWER, S.A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem., 270, 12953-12956.
24. MIZUKAMI, J. & TANIGUCHI, T. (1997). The antidiabetic agent thiazolidinedione stimulates the interaction between PPARγ and CBP. Biochem. Biophys. Res. Commun., 240, 61-64.
25. NADLER, J. & SCOTT, S. (1994). Evidence that pioglitazone increases intracellular free magnesium concentration in freshly isolated rat adipocytes. Biochem. Biophys. Res. Commun., 202, 416-421.
26. PAOLISSO, G., SGAMBATO, S., PIZZA, G., PASSARIELLO, N., VARRICCHIO, M. & IVONOFRIO, H. (1989). Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabets Care, 12, 265-269.
27. PAOLISSO, G., SCHEEN, A., D'ONOFRIO, F. & LEFÉBVRE, P. (1990). Magnesium and glucose homeostasis. Diabetologia, 33, 511-514.
28. RANDLE, P.J., GARLAND, P.B., HALES, C.N. & NEWSHOLME, E.A. (1963). The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lanect, i, 785-789.
29. REAVEN, G.M. & GREENFIELD, M.S. (1981). Diabetic hypertriglyØ ceridemia. Evidence for three clinical syndromes. Diabetes, 30 (Suppl. 2). 66-75.
30. RODBELL, M. (1964). Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem., 239, 375-380.
31. SALTIEL, A.R. & OLEFSKY, J.M. (1996). Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes, 45, 1661-1669.
32. SUÁREZ, A., PULIDO, N., CASLA, A., CASANOVA, B., ARRIETA, F.J. & ROVIRA, A. (1995). Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetalogia, 38, 1262-1270.
33. WILLSON, T.M., COBB, J.R., COWAN, D.J., WIETHE, R.W., CORREA, I.D., PRAKASH, S.R., BECK, K.D., MOORE, H.H., KLIEWER, S.A. & LEHMANN, J.M. (1996). The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem., 39, 665-668.
34. YOUNG, P.W., CAWTHORNE, M.A., COYLE, P.J., HOLDER, J.C., HOLMAN, G.D., KOZKA, I.J., KIRKHAM, D.M., LISTER, C.A. & SMITH, S.A. (1995). Repeat treatment of obese mice with BRL 49653, a new and potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by pholoallinity labeling. Diabetes, 44, 1087-1092.
35. ZHANG, B. SZALKOWSKI, D., DIAZ, E., HAYES, N., SMITH, R. & BERGER, J. (1994). Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. J. Biol. Chem., 269, 25735-25741.